Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study

To evaluate the acute and late toxicity using moderately hypofractionated, intensity-modulated radiotherapy (IMRT) with a simultaneous integrated boost (SIB) to prostate for patients with intermediate and high risk prostate cancer. From 2015 to 2017, 162 patients were treated with IMRT with SIB to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorgo, Kliton, Polgar, Csaba, Major, Tibor, Stelczer, Gabor, Herein, Andras, Pocza, Tamas, Gesztesi, Laszlo, Agoston, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242260/
https://www.ncbi.nlm.nih.gov/pubmed/30888646
http://dx.doi.org/10.1007/s12253-019-00623-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242260/
https://www.ncbi.nlm.nih.gov/pubmed/30888646
http://dx.doi.org/10.1007/s12253-019-00623-2

Ejemplares similares